Compare RMD & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | STZ |
|---|---|---|
| Founded | 1989 | 1945 |
| Country | United States | United States |
| Employees | 10600 | N/A |
| Industry | Medical/Dental Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2B | 27.2B |
| IPO Year | N/A | 1994 |
| Metric | RMD | STZ |
|---|---|---|
| Price | $209.13 | $152.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 19 |
| Target Price | ★ $292.56 | $175.63 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 04-30-2026 | 04-08-2026 |
| Dividend Yield | 1.13% | ★ 2.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $9,139,000,000.00 |
| Revenue This Year | $10.60 | $0.73 |
| Revenue Next Year | $7.41 | $1.93 |
| P/E Ratio | $25.61 | ★ $24.93 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $198.64 | $126.45 |
| 52 Week High | $293.81 | $196.91 |
| Indicator | RMD | STZ |
|---|---|---|
| Relative Strength Index (RSI) | 34.66 | 46.09 |
| Support Level | N/A | $147.73 |
| Resistance Level | $260.21 | $154.03 |
| Average True Range (ATR) | 5.43 | 4.17 |
| MACD | -0.92 | -1.07 |
| Stochastic Oscillator | 33.50 | 28.29 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.